Small cell lung cancer is a type of lung cancer that accounts for 10% to 15% of all lung malignancies. The cancer develops quickly in the lungs' tissue and typically spreads (metastasizes) outside the lungs by the time a person receives a diagnosis. Compared to other types of lung cancer, this cancer is also more likely to recur after therapy.
Small cell lung cancer is divided into two categories: small cell carcinoma and combined small cell carcinoma.
The most common site of small-cell carcinoma is the lungs, but it can affect any part of the body. It can spread quickly to other organs.
In combined small cell carcinoma, cancer tissues mostly contain small cell lung cancer (SCLC) components with histological characteristics of non-SCLC (NSCLC).
Early-stage small cell lung cancer that has not spread and is in the early stages usually exhibits few symptoms.
The following symptoms may be encountered by a patient as the condition progresses:
Small cell lung cancer (SCLC) can be treated using a variety of ways, depending on the type and extent of the disease.When SCLC has progressed to an advanced stage, treatment is focused on symptom relief rather than treating the root cause of illness.
Doctors consider surgery when there is only one tumor and cancer cells have not yet moved to other parts of the body. However, this is rarely the case when SCLC is diagnosed.
Chemotherapy is a type of aggressive drug therapy used to kill cancer cells. The drugs can be taken orally or given intravenously. They move via the blood circulation to kill cancer cells in different parts of the body.
In radiation therapy, cancer cells are targeted and destroyed using high-energy radiation beams during radiation treatment.
SCLC is diagnosed through a comprehensive physical examination and medical history evaluation.
Tests used to detect SCLC:
Our patients have access to a multispecialty team of professionals at ACTC, who work together in a highly collaborative and coordinated manner to provide all aspects of cancer care in one convenient location. Our doctors are supported by a clinical team with over two decades of experience and a reputation for providing tailored and supportive cancer care.
The following are our providers who you can consult at ACTC:
Cancer patients look for a sense of trust and care once diagnosed. At ACTC, we make it our priority to make them feel secure about the journey ahead. Our state-of-the-art mechanisms and dedicated team of specialists ensure world-class care. We handle everything from staging to treatment to long-term follow-up. With over 2 decades of experience in cancer treatment and care, our experienced team of cancer specialists and clinical staff are guaranteed to provide the best possible care.
Your form has been sent successfully.
According to many studies, SCLC is considered a type of fast-growing malignancy due to its neuroendocrinological origin, with doubling times (the amount of time it takes for a tumor to double in size) ranging from 25 to 217 days.
When the tumor is too close to other vital tissues, such as major veins of the lungs, cancer may be inoperable in such circumstances.
Lung nodules, non-small cell lung cancer, small cell lung cancer, and mesothelioma are the most common kinds of lung cancer.
If lung cancer is detected before it has progressed outside the lung, surgery is the best treatment option.